n/a
Abstract Title:

Natural silibinin modulates amyloid precursor protein processing and amyloid-β protein clearance in APP/PS1 mice.

Abstract Source:

J Physiol Sci. 2019 Jul ;69(4):643-652. Epub 2019 May 13. PMID: 31087219

Abstract Author(s):

Dafeng Bai, Ge Jin, Dajun Zhang, Lini Zhao, Mingyue Wang, Qiwen Zhu, Lin Zhu, Yan Sun, Xuan Liu, Xueying Chen, Liqian Zhang, Wenbo Li, Yan Cui

Article Affiliation:

Dafeng Bai

Abstract:

Silibinin has been shown to attenuate cognitive dysfunction and inhibit amyloid-beta (Aβ) aggregation in Alzheimer's disease (AD) models. However, the underlying mechanism by which silibinin improves cognition remains poorly understood. In this study, we investigated the effect of silibinin on β-secretase levels, Aβ enzymatic degradation, and oxidative stress in the brains of APP/PS1 mice with cognitive impairments. Oral administration of silibinin for 2 months significantly attenuated the cognitive deficits of APP/PS1 mice in the Y-maze test, novel object recognition test, and Morris water maze test. Biochemical analyses revealed that silibinin decreased Aβ deposition andthe levels of soluble Aβ1-40/1-42 in the hippocampus by downregulating APP and BACE1 and upregulating NEP in APP/PS1 mice. In addition, silibinin decreased the MDA content and increased the activities of the antioxidant enzymes CAT, SOD, and NO. Based on our findings, silibinin is a potentially promising agent for preventing AD-associated Aβ pathology.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.